[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clini-cians, 72, 7-33. https://doi.org/10.3322/caac.21708
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[3]
|
Conforti, F., Pala, L., Sala, I., Oriecuia, C., De Pas, T., Specchia, C., et al. (2021) Evaluation of Pathological Complete Response as Surrogate Endpoint in Neoadjuvant Randomised Clinical Trials of Early-Stage Breast Cancer: Systematic Review and Meta-Analysis. BMJ, 375, e066381. https://doi.org/10.1136/bmj-2021-066381
|
[4]
|
Li, J. and Jiang, Z. (2022) Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2022: Stratification and Classification. Cancer Biology & Medicine, 19, 769-773.
https://doi.org/10.20892/j.issn.2095-3941.2022.0277
|
[5]
|
Dubsky, P., Pinker, K., Cardoso, F., Montagna, G., Rit-ter, M., Denkert, C., et al. (2021) Breast Conservation and Axillary Management after Primary Systemic Therapy in Pa-tients with Early-Stage Breast Cancer: The Lucerne Toolbox. The Lancet Oncology, 22, e18-e28. https://doi.org/10.1016/S1470-2045(20)30580-5
|
[6]
|
Lee, S.C., Grant, E., Sheth, P., et al. (2017) Accuracy of Contrast-Enhanced Ultrasound Compared with Magnetic Resonance Imaging in Assessing the Tumor Response after Neoadjuvant Chemotherapy for Breast Cancer. Journal of Ultrasound in Medicine, 36, 901-911. https://doi.org/10.7863/ultra.16.05060
|
[7]
|
Man, V.C. and Cheung, P.S. (2017) Neoadjuvant Chemotherapy In-creases Rates of Breast-Conserving Surgery in Early Operable Breast Cancer. Hong Kong Medical Journal, 23, 251-257. https://doi.org/10.12809/hkmj164972
|
[8]
|
Boughey, J.C., Mccall, L.M., Ballman, K.V., et al. (2014) Tumor Biol-ogy Correlates with Rates of Breast-Conserving Surgery and Pathologic Complete Response after Neoadjuvant Chemo-therapy for Breast Cancer: Findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Annals of Surgery, 260, 608-616.
https://doi.org/10.1097/SLA.0000000000000924
|
[9]
|
Ahmed, S.H. (2019) Safety of Neoadjuvant Chemotherapy for the Treatment of Breast Cancer. Expert Opinion on Drug Safety, 18, 817-827. https://doi.org/10.1080/14740338.2019.1644318
|
[10]
|
Comes, M.C., La Forgia, D., Didonna, V., Fanizzi, A., Giotta, F., Latorre, A., et al. (2021) Early Prediction of Breast Cancer Recurrence for Patients Treated with Neoadjuvant Chemotherapy: A Transfer Learning Approach on DCE- MRIs. Cancers, 13, Article No. 2298. https://doi.org/10.3390/cancers13102298
|
[11]
|
Tahmassebi, A., Wengert, G.J., Helbich, T.H., Bago-Horvath, Z., Alaei, S., Bartsch, R., et al. (2019) Impact of Machine Learning with Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Pa-tients. Investigative Radiology, 54, 110-117.
https://doi.org/10.1097/RLI.0000000000000518
|
[12]
|
Suo, S., Yin, Y., Geng, X., Zhang, D., Hua, J., Cheng, F., et al. (2021) Diffusion-Weighted MRI for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: Evaluation with Mono-, Bi-, and Stretched-Exponential Models. Journal of Translational Medicine, 19, Article No. 236. https://doi.org/10.1186/s12967-021-02886-3
|
[13]
|
Chen, H., Li, W., Wan, C. and Zhang, J. (2022) Correlation of Dynamic Contrast-Enhanced MRI and Diffusion-Weighted MR Imaging with Prognostic Factors and Subtypes of Breast Cancers. Frontiers in Oncology, 12, Article ID: 942943. https://doi.org/10.3389/fonc.2022.942943
|
[14]
|
Shangguan, A.J., Sun, C., Wang, B., Pan, L., Ma, Q., Hu, S., Yang, J., et al. (2019) DWI and DCE-MRI Approaches for Differentiating Reversibly Electroporated Penumbra from Ir-reversibly Electroporated Ablation Zones in a Rabbit Liver Model. American Journal of Cancer Research, 9, 1982-1994.
|
[15]
|
Ling, D.C., Sutera, P.A., Iarrobino, N.A., Diego, E.J., Soran, A., Johnson, R.R., et al. (2019) Is Mul-tifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era after Neoadjuvant Chemo-therapy and Breast Conservation Therapy? International Journal of Radiation Oncology, Biology, Physics, 104, 869-876.
https://doi.org/10.1016/j.ijrobp.2019.03.012
|
[16]
|
Yoshikawa, K., Ishida, M., Kan, N., Yanai, H., Tsuta, K., Sekimoto, M., et al. (2020) Direct Comparison of Magnetic Resonance Imaging and Pathological Shrinkage Patterns of Triple-Negative Breast Cancer after Neoadjuvant Chemotherapy. World Journal of Surgical Oncology, 18, Article No. 177. https://doi.org/10.1186/s12957-020-01959-9
|
[17]
|
Zheng, C.H., Liu, Z.Y., Yuan, C.X., Dong, X.Y., Li, H.M., Wang, J.J., et al. (2021) Mutant Allele Frequency-Based Intra-Tumoral Genetic Heterogeneity Related to the Tumor Shrinkage Mode after Neoadjuvant Chemotherapy in Breast Cancer Patients. Frontiers in Medicine (Lausanne), 8, Arti-cle ID: 651904.
https://doi.org/10.3389/fmed.2021.651904
|
[18]
|
Fukada, I., Araki, K., Kobayashi, K., Shibayama, T., Takahashi, S., Gomi, N., et al. (2018) Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer. Radiology, 286, 49-57. https://doi.org/10.1148/radiol.2017161548
|
[19]
|
Wang, S., Zhang, Y., Yang, X., Fan, L., Qi, X., Chen, Q., et al. (2013) Shrink Pattern of Breast Cancer after Neoadjuvant Chemotherapy and Its Correlation with Clinical Pathological Factors. World Journal of Surgical Oncology, 11, Article No. 166. https://doi.org/10.1186/1477-7819-11-166
|
[20]
|
Kong, X., Moran, M.S., Zhang, N., Haffty, B. and Yang, Q. (2011) Meta-Analysis Confirms Achieving Pathological Complete Response after Neoadjuvant Chemotherapy Predicts Favourable Prognosis for Breast Cancer Patients. European Journal of Cancer, 47, 2084-2090. https://doi.org/10.1016/j.ejca.2011.06.014
|
[21]
|
Luangdilok, S., Samarnthai, N. and Korphaisarn, K. (2014) Associ-ation between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Ad-vanced Breast Cancer Patients. Journal of Breast Cancer, 17, 376-385. https://doi.org/10.4048/jbc.2014.17.4.376
|
[22]
|
Braman, N.M., Etesami, M., Prasanna, P., Dubchuk, C., Gilmore, H., Tiwari, P., Plecha, D. and Madabhushi, A. (2017) Intratumoral and Peritumoral Radiomics for the Pretreatment Pre-diction of Pathological Complete Response to Neoadjuvant Chemotherapy Based on Breast DCE-MRI. Breast Cancer Research, 19, Article No. 57.
https://doi.org/10.1186/s13058-017-0846-1
|
[23]
|
Partridge, S.C., Zhang, Z., Newitt, D.C., Gibbs, J.E., Chenevert, T.L., Rosen, M.A., et al. (2018) Diffusion-Weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treat-ment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology, 289, 618-627. https://doi.org/10.1148/radiol.2018180273
|
[24]
|
Symmans, W.F., Peintinger, F., Hatzis, C., Rajan, R., Kuerer, H., Valero, V., Assad, L., Poniecka, A., Hennessy, B., Green, M., et al. (2007) Measurement of Residual Breast Cancer Burden to Predict Survival after Neoadjuvant Chemotherapy. Journal of Clinical Oncology, 25, 4414-4422. https://doi.org/10.1200/JCO.2007.10.6823
|
[25]
|
Suo, S., Yin, Y., Geng, X., Zhang, D., Hua, J., Cheng, F., Chen, J., Zhuang, Z., Cao, M. and Xu, J. (2021) Diffusion-Weighted MRI for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: Evaluation with Mono-, Bi-, and Stretched-Exponential Models. Journal of Transla-tional Medicine, 19, Article No. 236.
https://doi.org/10.1186/s12967-021-02886-3
|
[26]
|
Gu, Y.L., Pan, S.M., Ren, J., Yang, Z.X. and Jiang, G.Q. (2017) Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Meta-Analysis. Clinical Breast Cancer, 17, 245-255. https://doi.org/10.1016/j.clbc.2016.12.010
|
[27]
|
Li, X.R., Cheng, L.Q., Liu, M., Zhang, Y.J., Wang, J.D., Zhang, A.L., et al. (2012) DW-MRI ADC Values Can Predict Treatment Response in Patients with Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy. Medical Oncology, 29, 425-431. https://doi.org/10.1007/s12032-011-9842-y
|